Resonic NDT
Resonic NDT is the commercial brand for the RESONIC™ medical device, which uses proprietary Rapid Acoustic Pulse (RAP)™ acoustic subcision technology to non-invasively reduce cellulite. It is sold by Soliton, Inc. (an AbbVie subsidiary) through Allergan Aesthetics to US dermatologists and aesthetic practices.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Resonic NDT does
Resonic NDT is the commercial brand for a non-invasive medical aesthetic device that targets the appearance of cellulite, owned and developed by Soliton, Inc. — a wholly-owned subsidiary of AbbVie Inc. operating within its Allergan Aesthetics division. The company's sole commercial offering is the RESONIC™ device, marketed to US-based dermatologists, medical aesthetic practices, and licensed aestheticians who deploy it as an in-office treatment for female patients affected by cellulite (a condition the company cites as affecting 9 of 10 US women). Resonic functions as a B2B2C medical device brand rather than a treatment provider: it sells hardware to practitioners and uses a consumer-facing website to drive patient demand toward those practitioners.
The device is built on the proprietary Rapid Acoustic Pulse (RAP)™ platform, which delivers high-frequency sound waves at 50–100 pulses per second to perform what the company terms "acoustic subcision" — a mechanical process that physically breaks apart the stiffened connective bands (septa) beneath the skin that cause cellulite dimpling, without cutting the skin, using needles, or administering anesthesia. Each treatment is a single session lasting 45–60 minutes, and the company cites a 93% patient satisfaction rate at 12 weeks and maintained satisfaction at 52 weeks from a clinical study.
Resonic monetizes through hardware device sales to healthcare providers, with financing options offered to practices that lower the upfront capital barrier. Go-to-market is a dual motion: enterprise field sales to providers (via a Healthcare Professional portal that captures NPI numbers and clinical credentials) paired with direct-to-consumer marketing on resonic.com that funnels prospective patients toward acquiring providers. The brand is promoted across Allergan Aesthetics' social channels (LinkedIn, Instagram, Facebook) and clinical credibility is anchored by a small set of named dermatologist endorsers. Distribution is direct-to-provider within the USA only, with no disclosed international operations, no app or software product surface, and no disclosed revenue or installed base.
Resonic NDT firmographics
Firmographics- Name
- Resonic NDT
- Legal name
- Soliton, Inc.
- Website
- https://resonic.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Resonic NDT is the commercial brand for the RESONIC™ medical device, which uses proprietary Rapid Acoustic Pulse (RAP)™ acoustic subcision technology to non-invasively reduce cellulite. It is sold by Soliton, Inc. (an AbbVie subsidiary) through Allergan Aesthetics to US dermatologists and aesthetic practices.
- Ownership category
- akta.pro rank
Resonic NDT business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Medical Device Sales: RESONIC sells its Rapid Acoustic Pulse device to healthcare providers (dermatologists, aesthetic practices) who use it to treat patients. The website mentions financing options available for practices, indicating device sales as the primary revenue stream.
- Treatment Services Revenue: Healthcare providers purchase the device and offer treatments to patients, generating revenue per treatment session. The company facilitates this through HCP partnerships and direct-to-consumer marketing to drive patient demand.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Resonic NDT product offering
Product offeringCore offering
Resonic sells the RESONIC™ medical aesthetic device, which uses proprietary Rapid Acoustic Pulse (RAP)™ technology to deliver high-frequency sound waves (50–100 cycles per second) that perform acoustic subcision to break apart the septa bands causing cellulite. The device is sold to dermatologists, aesthetic practices, and licensed aestheticians in the United States, who in turn use it to offer non-invasive, single-session cellulite reduction treatments to patients without surgery, needles, anesthesia, or downtime.
Product overview
RESONIC™ is a single unified medical device product for aesthetic/cosmetic treatment. The core offering consists of the RESONIC™ device itself, which is powered by the proprietary Rapid Acoustic Pulse (RAP)™ technology. This technology platform enables non-invasive cellulitis reduction treatment through acoustic subcision. The product is offered as one integrated system with no separate modules or add-ons mentioned.
Differentiator
Problem solved
Functional benefit
Products and services
- RESONIC™ Cellulite Reduction Device
Companies that use Resonic NDT
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
Resonic NDT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Resonic NDT partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Soliton, Inc. (AbbVie)coreSoliton, Inc. is the developer and original company behind the RESONIC technology. It was acquired by AbbVie and operates as a subsidiary under Allergan Aesthetics. RESONIC and its design are trademarks of Soliton, Inc., an AbbVie company.
Scale indicators3 records
Recent moves4 records
Expansion highlights3 records
Resonic NDT competitors and assessment
Company assessmentDirect peers
- Sciton, Inc. Sciton is a privately-held US manufacturer of laser and light-based aesthetic and medical platforms (BBL, Halo, Joule). It competes with RESONIC for the same dermatologist and plastic surgeon customers with non-invasive aesthetic technology.
- Lumenis Be Ltd. Lumenis is a global energy-based medical device company focused on aesthetic, surgical, and ophthalmic applications. Its aesthetic portfolio (e.g., ResurFX, M22) addresses body and skin treatments, making it a comparable direct competitor in the non-invasive device category.
- InMode Ltd. InMode is a leading energy-based aesthetic medical device company offering platforms for body contouring, skin tightening, and cellulite reduction (e.g., BodyTite, Morpheus8). It is highly comparable to RESONIC as both target dermatologists and aesthetic practices with non-invasive body contouring solutions sold via direct enterprise sales.
- BTL Industries: BTL Industries (now backed by Bain Capital) makes non-invasive body contouring and aesthetic devices such as Emsculpt, Emtone, and Exilis. Emtone in particular is a direct competitor for cellulite treatment, making BTL one of the closest direct peers to RESONIC's acoustic subcision device.
- Candela Medical: Candela Medical is a global aesthetic device company producing laser and energy-based systems (GentleLase, Vbeam, Nordlys) for body and skin treatments. It competes in the same providers/segments as RESONIC with non-invasive aesthetic procedures.
- Cutera, Inc. Cutera develops and markets aesthetic laser and energy-based devices (TruSculpt, AviClear, excel V) for body sculpting, skin rejuvenation, and dermatology. It is a direct competitor to RESONIC in the device-based non-invasive aesthetic treatment space, targeting the same HCP customer base.
- Venus Concept Inc. Venus Concept manufactures aesthetic devices (Venus Bliss, Venus Legacy, Venus Versa) for body contouring, cellulite reduction, and skin rejuvenation. It is a direct competitor to RESONIC with a similar go-to-market targeting aesthetic practices and medspas.
- Cynosure (Hologic): Cynosure, acquired by Hologic, is an aesthetic medical device manufacturer offering body contouring (TempSure, SculpSure) and skin treatment systems. It directly competes with RESONIC in the dermatology/aesthetic practitioner channel with non-invasive energy-based platforms.
- Alma Lasers: Alma Lasers (a Sisram Medical company) is a leading global provider of energy-based aesthetic devices, including platforms for body contouring and skin tightening (Accent, Alma Harmony). It is comparable to RESONIC as a direct competitor selling non-invasive devices to dermatologists and aesthetic practices.
- Solta Medical (Bausch Health): Solta Medical, a division of Bausch Health, manufactures the Thermage, Fraxel, and Clear + Brilliant systems for skin tightening and rejuvenation. It overlaps with RESONIC in selling premium aesthetic devices to dermatologists and plastic surgeons, and competes in the body/skin treatment category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Resonic NDT social profiles
Digital presenceResonic NDT financial estimates
Financial estimateRevenue estimate
Valuation estimate
Resonic NDT leadership team
Management profileNumber of profiles
Resonic NDT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Resonic NDT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Resonic NDT
What does Resonic NDT do?
Resonic sells the RESONIC™ medical aesthetic device, which uses proprietary Rapid Acoustic Pulse (RAP)™ technology to deliver high-frequency sound waves (50–100 cycles per second) that perform acoustic subcision to break apart the septa bands causing cellulite. The device is sold to dermatologists, aesthetic practices, and licensed aestheticians in the United States, who in turn use it to offer non-invasive, single-session cellulite reduction treatments to patients without surgery, needles, anesthesia, or downtime.
Is Resonic NDT a public or private company?
Resonic NDT is a private company. It is classified as corporate owned and is currently operating.
When was Resonic NDT founded?
Resonic NDT was founded in -1. It employs 1 to 10 people.
How does Resonic NDT make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are treatment Services Revenue.
Who are Resonic NDT's main competitors?
Direct peers on record are Sciton, Inc., Lumenis Be Ltd., InMode Ltd., BTL Industries, Candela Medical, Cutera, Inc., Venus Concept Inc., Cynosure (Hologic), Alma Lasers and Solta Medical (Bausch Health).
Does Resonic NDT have an API?
No public API is recorded for Resonic NDT.